Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 1,552,520  
Prepaid expenses and other current assets 467,371  
Total Current Assets 2,019,891  
Deferred offering costs   $ 197,790
Investments held in Trust Account 345,089,823  
TOTAL ASSETS 347,109,714 197,790
Current liabilities    
Accounts payable and accrued expenses 2,140,014 6,093
Accrued offering costs 12,000 120,540
Advances from related party 5,360  
Promissory note - related party   52,250
Total Current Liabilities 2,157,374 178,883
Warrant liabilities 16,405,000  
Deferred underwriting fee payable 12,075,000  
Total Liabilities 30,637,374 178,883
Commitments and contingencies
Shareholders' (Deficit) Equity    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital   24,137
Accumulated deficit (28,528,523) (6,093)
Total Shareholders' (Deficit) Equity (28,527,660) 18,907
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY 347,109,714 197,790
Class A Ordinary shares subject to possible redemption    
Current liabilities    
Class A ordinary shares subject to possible redemption, $0.0001 par value, 34,500,000 and no shares issued and outstanding at $10.00 per share redemption value as of December 31, 2021 and 2020, respectively 345,000,000  
Class B Ordinary shares    
Shareholders' (Deficit) Equity    
Common stock $ 863 $ 863